These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 15718154)

  • 1. Chris Ashton talks about his career and the recent merger of Argenta Discovery and Etiologics. Interview by Steve Carney.
    Ashton C
    Drug Discov Today; 2005 Jan; 10(2):82-5. PubMed ID: 15718154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Joseph Miletich talks about big Pharma, biotech and the future of Amgen. Interview by Steve Carney.
    Miletich JP
    Drug Discov Today; 2006 Mar; 11(5-6):188-90. PubMed ID: 16580595
    [No Abstract]   [Full Text] [Related]  

  • 3. Steve Carney talks to Mark Ashton and Mark Whittaker about Evotec and their approach to fragment-based drug discovery.
    Ashton M; Whittaker M
    Drug Discov Today; 2007 Oct; 12(19-20):789-93. PubMed ID: 18019952
    [No Abstract]   [Full Text] [Related]  

  • 4. Etiologics ltd.
    Campbell DA; Fitzgerald MF
    Pharmacogenomics; 2003 May; 4(3):351-7. PubMed ID: 12718725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A brave new medicine. A conversation with William Haseltine.. Interview by Joe Flower.
    Hasetine W
    Health Forum J; 1999; 42(4):28-30, 61-5. PubMed ID: 10539016
    [No Abstract]   [Full Text] [Related]  

  • 6. Case study: impact of technology investment on lead discovery at Bristol-Myers Squibb, 1998-2006.
    Houston JG; Banks MN; Binnie A; Brenner S; O'Connell J; Petrillo EW
    Drug Discov Today; 2008 Jan; 13(1-2):44-51. PubMed ID: 18190863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opportunities and challenges in the discovery of new central nervous system drugs.
    Krause JE; Chenard BL
    Ann N Y Acad Sci; 2008 Nov; 1144():243-50. PubMed ID: 19076381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming the work of early-stage drug discovery through bioprocess informatics.
    Holzman TF; Hebert EJ
    Drug Discov Today; 2005 Jan; 10(1):61-7. PubMed ID: 15676300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peter Corr outlines Pfizer's approach to innovation, maximizing capabilities and delivering essential medicine. Interview by Steve Carney.
    Corr PB
    Drug Discov Today; 2005 Aug; 10(15):1017-20. PubMed ID: 16055016
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of mergers and acquisitions on drug discovery: perspective from a case study of a Japanese pharmaceutical company.
    Shibayama S; Tanikawa K; Fujimoto R; Kimura H
    Drug Discov Today; 2008 Jan; 13(1-2):86-93. PubMed ID: 18190869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hunt for a new drug: five views from the inside.
    Mervis J
    Science; 2005 Jul; 309(5735):722. PubMed ID: 16051781
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug discovery and natural products: end of an era or an endless frontier?
    Li JW; Vederas JC
    Science; 2009 Jul; 325(5937):161-5. PubMed ID: 19589993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathways across the valley of death: novel intellectual property strategies for accelerated drug discovery.
    Rai AK; Reichman JH; Uhlir PF; Crossman C
    Yale J Health Policy Law Ethics; 2008; 8(1):1-36. PubMed ID: 18564492
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug Discovery Technology and Development 2005 - IBC's Tenth World Congress. Emerging and early stage company showcase pre-conference symposium.
    Razvi ES
    IDrugs; 2005 Oct; 8(10):796-8. PubMed ID: 16254794
    [No Abstract]   [Full Text] [Related]  

  • 15. Timely synthetic support for medicinal chemists.
    Potoski J
    Drug Discov Today; 2005 Jan; 10(2):115-20. PubMed ID: 15718160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical investigators: the driving force behind drug discovery.
    Gutterman JU
    Nat Biotechnol; 1997 Jul; 15(7):598-9. PubMed ID: 9219248
    [No Abstract]   [Full Text] [Related]  

  • 17. Partnership between academia and industry for drug discovery in Alzheimer's disease.
    Ivinson AJ; Lane R; May PC; Hosford DA; Carrillo MC; Siemers ER
    Alzheimers Dement; 2008 Mar; 4(2):80-8. PubMed ID: 18631952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Patent rights and the free research. The boundary between basic research and private sector is not longer razor-sharp].
    Westerlund L
    Lakartidningen; 2005 Sep 26-Oct 2; 102(39):2737. PubMed ID: 16245544
    [No Abstract]   [Full Text] [Related]  

  • 19. Where is the optimism? Warrior teachings to regain the drug discovery spirit.
    Uitdehaag JC
    Drug Discov Today; 2007 Feb; 12(3-4):105-7. PubMed ID: 17275729
    [No Abstract]   [Full Text] [Related]  

  • 20. Graham Dixon talks about his career, his involvement with the Society for Chemical Industries and the development of SCIpharm2006. Interview by Steve Carney.
    Dixon G
    Drug Discov Today; 2006 Apr; 11(7-8):280-2. PubMed ID: 17233109
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.